Company Filing History:
Years Active: 2006
Title: The Innovative Mind of Albion E. Baucom
Introduction
Albion E. Baucom, based in Santa Cruz, California, is a prominent inventor known for his contributions to the field of molecular biology, specifically in understanding ribosome structures. With a focus on X-ray crystallography, Baucom's innovative work has opened new avenues for research and drug development.
Latest Patents
Baucom holds a patent for his groundbreaking work titled “X-ray crystal structures of functional ribosome complexes containing transfer RNA and model messenger RNAs and methods of use.” This patent details the 5.5 angstrom resolution X-ray crystallographic structures of 70S ribosome complexes. These complexes contain messenger RNA and transfer RNA (tRNA), or tRNA analogs. By fitting atomic resolution structures of the 30S and 50S subunits onto the electron density map, Baucom enhances the structural understanding of these complexes. This advancement not only reveals structural differences between the 70S complex and the individual components but also paves the way for pharmacophore design aimed at identifying novel inhibitors or activators.
Career Highlights
Albion E. Baucom is affiliated with the University of California, where he has advanced his research in the field of biochemistry and structural biology. His work is significant in the study of ribosome function and its implications in genetic coding and protein synthesis.
Collaborations
Throughout his career, Baucom has had the opportunity to collaborate with esteemed scientists such as Harry F. Noller and Jamie H. D. Cate. These collaborations have helped to enrich the research, combining their expertise to broaden the impact of their findings in the scientific community.
Conclusion
Albion E. Baucom's innovative contributions to the field of molecular biology exemplify the importance of research in understanding complex biological systems. His patented work serves not only as a testament to his ingenuity but also as a foundation for future discoveries that could lead to novel therapeutic interventions.